BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 23426727)

  • 1. Bladder dysfunction in a transgenic mouse model of multiple system atrophy.
    Boudes M; Uvin P; Pinto S; Voets T; Fowler CJ; Wenning GK; De Ridder D; Stefanova N
    Mov Disord; 2013 Mar; 28(3):347-55. PubMed ID: 23426727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progressive striatonigral degeneration in a transgenic mouse model of multiple system atrophy: translational implications for interventional therapies.
    Refolo V; Bez F; Polissidis A; Kuzdas-Wood D; Sturm E; Kamaratou M; Poewe W; Stefanis L; Angela Cenci M; Romero-Ramos M; Wenning GK; Stefanova N
    Acta Neuropathol Commun; 2018 Jan; 6(1):2. PubMed ID: 29298733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oligodendroglial alpha-synucleinopathy and MSA-like cardiovascular autonomic failure: experimental evidence.
    Kuzdas D; Stemberger S; Gaburro S; Stefanova N; Singewald N; Wenning GK
    Exp Neurol; 2013 Sep; 247():531-6. PubMed ID: 23399889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic proteasome inhibition triggers neurodegeneration in a transgenic mouse model expressing human α-synuclein under oligodendrocyte promoter: implications for multiple system atrophy.
    Stefanova N; Kaufmann WA; Humpel C; Poewe W; Wenning GK
    Acta Neuropathol; 2012 Jul; 124(1):51-65. PubMed ID: 22491959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Failure of Neuroprotection Despite Microglial Suppression by Delayed-Start Myeloperoxidase Inhibition in a Model of Advanced Multiple System Atrophy: Clinical Implications.
    Kaindlstorfer C; Sommer P; Georgievska B; Mather RJ; Kugler AR; Poewe W; Wenning GK; Stefanova N
    Neurotox Res; 2015 Oct; 28(3):185-94. PubMed ID: 26194617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-related motor dysfunction and neuropathology in a transgenic mouse model of multiple system atrophy.
    Fernagut PO; Meissner WG; Biran M; Fantin M; Bassil F; Franconi JM; Tison F
    Synapse; 2014 Mar; 68(3):98-106. PubMed ID: 24243499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotection by Epigenetic Modulation in a Transgenic Model of Multiple System Atrophy.
    Sturm E; Fellner L; Krismer F; Poewe W; Wenning GK; Stefanova N
    Neurotherapeutics; 2016 Oct; 13(4):871-879. PubMed ID: 27259295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of Peripheral Nerves in the Transgenic PLP-α-Syn Model of Multiple System Atrophy: Extending the Phenotype.
    Kuzdas-Wood D; Irschick R; Theurl M; Malsch P; Mair N; Mantinger C; Wanschitz J; Klimaschewski L; Poewe W; Stefanova N; Wenning GK
    PLoS One; 2015; 10(10):e0136575. PubMed ID: 26496712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurodegeneration in a transgenic mouse model of multiple system atrophy is associated with altered expression of oligodendroglial-derived neurotrophic factors.
    Ubhi K; Rockenstein E; Mante M; Inglis C; Adame A; Patrick C; Whitney K; Masliah E
    J Neurosci; 2010 May; 30(18):6236-46. PubMed ID: 20445049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted overexpression of human alpha-synuclein in oligodendroglia induces lesions linked to MSA-like progressive autonomic failure.
    Stemberger S; Poewe W; Wenning GK; Stefanova N
    Exp Neurol; 2010 Aug; 224(2):459-64. PubMed ID: 20493840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic potential of iron modulating drugs in a mouse model of multiple system atrophy.
    Shukla JJ; Stefanova N; Bush AI; McColl G; Finkelstein DI; McAllum EJ
    Neurobiol Dis; 2021 Nov; 159():105509. PubMed ID: 34537326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rasagiline is neuroprotective in a transgenic model of multiple system atrophy.
    Stefanova N; Poewe W; Wenning GK
    Exp Neurol; 2008 Apr; 210(2):421-7. PubMed ID: 18222424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptomic insights into multiple system atrophy from a PLP-α-synuclein transgenic mouse model.
    Nicholson L; Piras IS; DeBoth MD; Siniard A; Heras-Garvin A; Stefanova N; Huentelman MJ
    Brain Res; 2024 Jul; 1834():148912. PubMed ID: 38575106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-synuclein transgenic mice: relevance to multiple system atrophy.
    Fillon G; Kahle PJ
    Mov Disord; 2005 Aug; 20 Suppl 12():S64-6. PubMed ID: 16092093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in the miRNA-mRNA Regulatory Network Precede Motor Symptoms in a Mouse Model of Multiple System Atrophy: Clinical Implications.
    Schafferer S; Khurana R; Refolo V; Venezia S; Sturm E; Piatti P; Hechenberger C; Hackl H; Kessler R; Willi M; Gstir R; Krogsdam A; Lusser A; Poewe W; Wenning GK; Hüttenhofer A; Stefanova N
    PLoS One; 2016; 11(3):e0150705. PubMed ID: 26962858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anle138b modulates α-synuclein oligomerization and prevents motor decline and neurodegeneration in a mouse model of multiple system atrophy.
    Heras-Garvin A; Weckbecker D; Ryazanov S; Leonov A; Griesinger C; Giese A; Wenning GK; Stefanova N
    Mov Disord; 2019 Feb; 34(2):255-263. PubMed ID: 30452793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial inhibitor 3-nitroproprionic acid enhances oxidative modification of alpha-synuclein in a transgenic mouse model of multiple system atrophy.
    Ubhi K; Lee PH; Adame A; Inglis C; Mante M; Rockenstein E; Stefanova N; Wenning GK; Masliah E
    J Neurosci Res; 2009 Sep; 87(12):2728-39. PubMed ID: 19405128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Mouse Model of Multiple System Atrophy: Bench to Bedside.
    Stefanova N
    Neurotherapeutics; 2023 Jan; 20(1):117-126. PubMed ID: 35995919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. α-Synuclein-induced myelination deficit defines a novel interventional target for multiple system atrophy.
    Ettle B; Kerman BE; Valera E; Gillmann C; Schlachetzki JC; Reiprich S; Büttner C; Ekici AB; Reis A; Wegner M; Bäuerle T; Riemenschneider MJ; Masliah E; Gage FH; Winkler J
    Acta Neuropathol; 2016 Jul; 132(1):59-75. PubMed ID: 27059609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological inhibition of FABP7 by MF 6 counteracts cerebellum dysfunction in an experimental multiple system atrophy mouse model.
    Cheng A; Jia W; Finkelstein DI; Stefanova N; Wang H; Sasaki T; Kawahata I; Fukunaga K
    Acta Pharmacol Sin; 2024 Jan; 45(1):66-75. PubMed ID: 37605049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.